| SpectraBase Spectrum ID |
5ZCy8eaGz5M |
| Name |
1,3-Di-(2-hexyl)-3-benzoyl-2-methylindole |
| Classification |
Aroylindole cannabinoid designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
299.261300067 u |
| Formula |
C21H33N |
| InChI |
InChI=1S/C21H33N/c1-6-8-12-16(3)21-18(5)22(17(4)13-9-7-2)20-15-11-10-14-19(20)21/h10-11,14-17H,6-9,12-13H2,1-5H3 |
| InChIKey |
YJJOBVHEVMSTOX-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
299.502 g/mol |
| Nominal Mass |
299 u |
| Quality |
899 |
| Retention Index |
2079 |
| SMILES |
C=12N(C(=C(C2=CC=CC1)C(CCCC)C)C)C(CCCC)C |
| SPLASH |
splash10-0006-6970000000-538f6e618a2eaef634ac |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Indole,1,3-di-(2-hexyl)-3-benzoyl-2-methyl
1,3-Di-(2-hexyl)-3-benzoyl-2-methyl-1H-indole |
| Technique |
GC/MS |
| Wiley ID |
DD2024_015337 |
